These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G. Cancer Res; 2000 Jun 15; 60(12):3305-12. PubMed ID: 10866325 [Abstract] [Full Text] [Related]
5. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Meurs H, Hamer MA, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J. Br J Pharmacol; 2000 Aug 15; 130(8):1793-8. PubMed ID: 10952667 [Abstract] [Full Text] [Related]
6. N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Boucher JL, Custot J, Vadon S, Delaforge M, Lepoivre M, Tenu JP, Yapo A, Mansuy D. Biochem Biophys Res Commun; 1994 Sep 30; 203(3):1614-21. PubMed ID: 7945311 [Abstract] [Full Text] [Related]
7. Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Buga GM, Singh R, Pervin S, Rogers NE, Schmitz DA, Jenkinson CP, Cederbaum SD, Ignarro LJ. Am J Physiol; 1996 Nov 30; 271(5 Pt 2):H1988-98. PubMed ID: 8945918 [Abstract] [Full Text] [Related]
8. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Jung C, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J. Cardiovasc Res; 2010 Jan 01; 85(1):147-54. PubMed ID: 19726439 [Abstract] [Full Text] [Related]
9. Modulation of intrinsic cavernous tone and nitric oxide production by arginase in rabbit corpus cavernosum. Masuda H, Yano M, Sakai Y, Kihara K, Yamauchi Y, Azuma H. J Urol; 2004 Jan 01; 171(1):490-4. PubMed ID: 14665961 [Abstract] [Full Text] [Related]
10. Regulation of the urea cycle enzyme genes in nitric oxide synthesis. Mori M, Gotoh T, Nagasaki A, Takiguchi M, Sonoki T. J Inherit Metab Dis; 1998 Jan 01; 21 Suppl 1():59-71. PubMed ID: 9686345 [Abstract] [Full Text] [Related]
16. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. El-Gayar S, Thüring-Nahler H, Pfeilschifter J, Röllinghoff M, Bogdan C. J Immunol; 2003 Nov 01; 171(9):4561-8. PubMed ID: 14568929 [Abstract] [Full Text] [Related]
18. Arginase modulates nitric oxide production in activated macrophages. Chang CI, Liao JC, Kuo L. Am J Physiol; 1998 Jan 01; 274(1):H342-8. PubMed ID: 9458885 [Abstract] [Full Text] [Related]
19. Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. Topal G, Brunet A, Walch L, Boucher JL, David-Dufilho M. J Pharmacol Exp Ther; 2006 Sep 01; 318(3):1368-74. PubMed ID: 16801455 [Abstract] [Full Text] [Related]
20. Normal circulating adult human red blood cells contain inactive NOS proteins. Kang ES, Ford K, Grokulsky G, Wang YB, Chiang TM, Acchiardo SR. J Lab Clin Med; 2000 Jun 01; 135(6):444-51. PubMed ID: 10850643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]